| GTO ID | GTC1213 |
| Trial ID | NCT00072098 |
| Disease | Colorectal Cancer |
| Altered gene | IL-12 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Adv-IL12 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase I Trial Of Adenoviral Vector Delivery Of The Human Interleukin-12 cDNA By Intratumoral Injection In Patients With Metastatic Colorectal Cancer To The Liver |
| Year | 2003 |
| Country | United States |
| Company sponsor | Max Sung |
| Other ID(s) | GCO 97-0564|MTS-GCO-975642|MTS-GCO-971592|CDR0000335463|NIH 9911-359 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||